PNC Financial Services Group
GPCR icon

PNC Financial Services Group’s Structure Therapeutics GPCR Stock Holding History

PNC Financial Services Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Sell
2,782
-72
-3% -$3.19K ﹤0.01% 2668
2026
Q1 		$138K Sell
2,854
-1,072
-27% -$73.4K ﹤0.01% 2593
2025
Q4 		$273K Sell
3,926
-902
-19% -$36.8K ﹤0.01% 2072
2025
Q3 		$135K Buy
4,828
+413
+9% +$8.23K ﹤0.01% 2594
2025
Q2 		$91.6K Buy
4,415
+994
+29% +$21.9K ﹤0.01% 2765
2025
Q1 		$59.2K Buy
3,421
+144
+4% +$3.53K ﹤0.01% 2994
2024
Q4 		$88.9K Sell
3,277
-42
-1% -$1.49K ﹤0.01% 2752
2024
Q3 		$146K Buy
3,319
+7
+0.2% +$271 ﹤0.01% 2435
2024
Q2 		$130K Buy
3,312
+3,253
+5,514% +$134K ﹤0.01% 2445
2024
Q1 		$2.53K Buy
59
+9
+18% +$380 ﹤0.01% 4141
2023
Q4 		$2.04K Buy
+50
New +$2.87K ﹤0.01% 4185

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

PNC Financial Services Group's GPCR Position: Q2 2026 in Review

PNC Financial Services Group reduced its Structure Therapeutics (GPCR) stake by 2.5% in Q2 2026, selling an estimated $3.19K and leaving 2,782 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #2668.

PNC Financial Services Group first reported a position in GPCR in Q4 2023 and has held it in 11 quarters since. The position peaked at $273K in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • PNC Financial Services Group held 2,782 shares of Structure Therapeutics worth $149K as of Q2 2026.
  • PNC Financial Services Group sold 72 Structure Therapeutics shares in Q2 2026, an estimated $3.19K.
  • Structure Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2668 holding.
  • PNC Financial Services Group first reported a position in Structure Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • PNC Financial Services Group's Structure Therapeutics position peaked at $273K in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.